Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), often reffered to as malignant hepatoma. It is the most common type of hepato cancer. Most cases of hepato cancer are as a result of either a viral hepatitis infection (hepatitis B or C), metabolic toxins such as alcohol or aflatoxin, conditions like hemochromatosis. Treatment options for HCC and prognosis are dependent on many factors but especially on tumor size, staging, and extent of hepatic injury. High-grade tumors will have a poor prognosis, while low-grade tumors may unnoticed for many years.

 

  • Hepatocellular disease
  • Fibrolamellar hepatocellular carcinoma
  • Hepatocellular cancer
  • Metastatic hepatocellular carcinoma
  • Multifocal hepatocellular carcinoma
  • Upper GI x-ray

Related Conference of Hepatocellular Carcinoma

December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
January 30-31, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Radisson Hotel Narita | Tokyo, Japan
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
April 24-25, 2019

International conference on Liver and Hepatitis

Budapest, Hungary
May 15-16, 2019

21st World Congress on Advances in Gastroenterology and Hepatology

Mercure Melbourne Albert Park, Melbourne, Australia
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in